Last €36.17 EUR
Change Today +0.63 / 1.76%
Volume 53.1K
FAGR On Other Exchanges
Symbol
Exchange
EN Brussels
Berlin
OTC US
As of 11:38 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

fagron (FAGR) Snapshot

Open
€35.54
Previous Close
€35.55
Day High
€36.33
Day Low
€35.49
52 Week High
08/5/14 - €44.98
52 Week Low
02/4/14 - €26.31
Market Cap
1.1B
Average Volume 10 Days
64.5K
EPS TTM
€1.62
Shares Outstanding
31.4M
EX-Date
05/14/14
P/E TM
22.4x
Dividend
€0.72
Dividend Yield
1.99%
Current Stock Chart for FAGRON (FAGR)

Related News

No related news articles were found.

fagron (FAGR) Related Businessweek News

No Related Businessweek News Found

fagron (FAGR) Details

Fagron NV, a research and development scientific company, provides solutions and concepts to professionals and institutions in the healthcare sector worldwide. It operates through three segments: Fagron, Corilus, and HL Technology. The Fagron segment provides products and services for pharmaceutical compounding. This segment develops and markets pharmaceutical formulas; sells and distributes instruments and pharmaceutical raw materials for pharmaceutical compounding; sells and distributes compounded and products under the brand Fagron to pharmacists; provides third-party pharmaceutical compounding services to pharmacists and hospitals; and offers specialty pharmaceutical raw materials to the pharmaceutical industries. The Corilus segment provides ICT solutions for various medical and paramedical professions, such as pharmacists, dentists, GPs, ophthalmologists, veterinarians, nurses, residential care centers, physiotherapists, midwives, opticians, hospitals, and insurers. The HL Technology segment develops and produces healthcare devices, including orthopedic instruments, MedTech-dentistry, and other precision components for the dental and medical orthopedic industries. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV is based in Waregem, Belgium.

1,902 Employees
Last Reported Date: 04/10/14

fagron (FAGR) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: €1.1M
Compensation as of Fiscal Year 2013.

fagron (FAGR) Key Developments

Arseus NV Approves Amendments to Articles of Association

Arseus NV announced that at the Extraordinary General Meeting of Shareholders of the company held on 12 December 2014, approved the amendments to the articles of association.

Arseus NV has Changed its Name to Fagron NV

On December 12, 2014, Arseus NV changed its name to Fagron NV.

Arseus NV Proposes Amendment of Articles of Association

Arseus NV announced that an first extraordinary shareholders' meeting will be held on December 12, 2014, to approve to change the company's name from Arseus into Fagron effective as from January 1, 2015 and to consequently amend Article 1 of the articles of association, to authorize the acquisition and disposal of treasury shares - amendment of Article 53 of the articles of association and to approve other amendments to the articles of association.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FAGR:BB €36.17 EUR +0.63

FAGR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Henry Schein Inc $138.07 USD -1.94
View Industry Companies
 

Industry Analysis

FAGR

Industry Average

Valuation FAGR Industry Range
Price/Earnings 17.8x
Price/Sales 2.1x
Price/Book 6.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FAGRON, please visit www.arseus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.